rs150857128

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012309.5(SHANK2):​c.4991T>C​(p.Ile1664Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0046 in 1,603,872 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. I1664I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 22 hom. )

Consequence

SHANK2
NM_012309.5 missense

Scores

1
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.62

Publications

10 publications found
Variant links:
Genes affected
SHANK2 (HGNC:14295): (SH3 and multiple ankyrin repeat domains 2) This gene encodes a protein that is a member of the Shank family of synaptic proteins that may function as molecular scaffolds in the postsynaptic density of excitatory synapses. Shank proteins contain multiple domains for protein-protein interaction, including ankyrin repeats, and an SH3 domain. This particular family member contains a PDZ domain, a consensus sequence for cortactin SH3 domain-binding peptides and a sterile alpha motif. The alternative splicing demonstrated in Shank genes has been suggested as a mechanism for regulating the molecular structure of Shank and the spectrum of Shank-interacting proteins in the postsynaptic densities of the adult and developing brain. Alterations in the encoded protein may be associated with susceptibility to autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
SHANK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autism, susceptibility to, 17
    Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004924059).
BP6
Variant 11-70473428-A-G is Benign according to our data. Variant chr11-70473428-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212168.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00364 (554/152200) while in subpopulation NFE AF = 0.00544 (370/68006). AF 95% confidence interval is 0.00498. There are 1 homozygotes in GnomAd4. There are 279 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 554 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012309.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK2
NM_012309.5
MANE Select
c.4991T>Cp.Ile1664Thr
missense
Exon 26 of 26NP_036441.2Q9UPX8-3
SHANK2
NM_001441024.1
c.5111T>Cp.Ile1704Thr
missense
Exon 24 of 24NP_001427953.1
SHANK2
NM_001441025.1
c.4940T>Cp.Ile1647Thr
missense
Exon 23 of 23NP_001427954.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK2
ENST00000601538.6
TSL:5 MANE Select
c.4991T>Cp.Ile1664Thr
missense
Exon 26 of 26ENSP00000469689.2Q9UPX8-3
SHANK2
ENST00000409161.5
TSL:1
c.3203T>Cp.Ile1068Thr
missense
Exon 10 of 10ENSP00000386491.1E7EUA2
SHANK2
ENST00000916035.1
c.4940T>Cp.Ile1647Thr
missense
Exon 23 of 23ENSP00000586094.1

Frequencies

GnomAD3 genomes
AF:
0.00364
AC:
554
AN:
152082
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000725
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00970
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00544
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00394
AC:
951
AN:
241270
AF XY:
0.00422
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.00188
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00976
Gnomad NFE exome
AF:
0.00588
Gnomad OTH exome
AF:
0.00346
GnomAD4 exome
AF:
0.00470
AC:
6825
AN:
1451672
Hom.:
22
Cov.:
32
AF XY:
0.00477
AC XY:
3445
AN XY:
722488
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33474
American (AMR)
AF:
0.00166
AC:
74
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00228
AC:
197
AN:
86248
European-Finnish (FIN)
AF:
0.00947
AC:
411
AN:
43416
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5764
European-Non Finnish (NFE)
AF:
0.00531
AC:
5907
AN:
1111896
Other (OTH)
AF:
0.00338
AC:
204
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
393
786
1179
1572
1965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00364
AC:
554
AN:
152200
Hom.:
1
Cov.:
32
AF XY:
0.00375
AC XY:
279
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.000723
AC:
30
AN:
41504
American (AMR)
AF:
0.00170
AC:
26
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4822
European-Finnish (FIN)
AF:
0.00970
AC:
103
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00544
AC:
370
AN:
68006
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00477
Hom.:
7
Bravo
AF:
0.00290
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00434
AC:
527
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00523
EpiControl
AF:
0.00480

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Autism, susceptibility to, 17 (2)
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
18
DANN
Benign
0.74
DEOGEN2
Benign
0.0030
T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.15
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-1.1
T
PhyloP100
1.6
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.18
N
REVEL
Benign
0.23
Sift
Benign
0.40
T
Sift4G
Benign
0.77
T
Polyphen
0.0020
B
Vest4
0.17
MVP
0.39
MPC
0.59
ClinPred
0.013
T
GERP RS
4.8
gMVP
0.18
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150857128; hg19: chr11-70319533; COSMIC: COSV107311425; COSMIC: COSV107311425; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.